G. Merki-Feld

发表

Dealing with Headache: Sex Differences in the Burden of Migraine- and Tension-Type Headache

H. Pohl, M. Neumeier, P. Sándor, 2021, Brain sciences.

Nonpalpable ultrasonographically not detectable Implanon rods can be localized by magnetic resonance imaging.

G. Merki-Feld, P. Keller, C. Brekenfeld, 2001, Contraception.

Migraine, low-dose combined hormonal contraceptives, and ischemic stroke in young women: a systematic review and suggestions for future research

T. Kurth, S. Sacco, G. Merki-Feld, 2020, Expert review of neurotherapeutics.

Implanon use lowers plasma concentrations of high-molecular-weight adiponectin.

K. Spanaus, G. Merki-Feld, B. Imthurn, 2011, Fertility and sterility.

Effect of desogestrel 75 µg on headache frequency and intensity in women with migraine: a prospective controlled trial

P. Sándor, G. Merki-Feld, A. Gantenbein, 2019, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Temporal relations in hormone-withdrawal migraines and impact on prevention- a diary-based pilot study in combined hormonal contraceptive users

B. Seifert, P. Sándor, G. Merki-Feld, 2017, The Journal of Headache and Pain.

Hormonal contraception in women with migraine: is progestogen-only contraception a better choice?

G. Merki-Feld, M. Viana, R. Nappi, 2013, The Journal of Headache and Pain.

Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)

T. Kurth, S. Sacco, G. Merki-Feld, 2017, The Journal of Headache and Pain.

Effects of the Progestagen-only Contraceptive Implant Implanon® on Transforming Growth Factor β1 and Endothelin-1

B. Seifert, G. Merki-Feld, B. Imthurn, 2008, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Serum concentrations of high-molecular weight adiponectin and their association with sex steroids in premenopausal women.

K. Spanaus, G. Merki-Feld, B. Imthurn, 2011, Metabolism: clinical and experimental.

Effects of two oral contraceptives on plasma levels of nitric oxide, homocysteine, and lipid metabolism.

G. Merki-Feld, B. Imthurn, P. Keller, 2002, Metabolism: clinical and experimental.

A 2-year prospective study on the effects of depot medroxyprogesterone acetate on bone mass-response to estrogen and calcium therapy in individual users.

G. Merki-Feld, M. Neff, P. Keller, 2003, Contraception.

Piperine Decreases Binding of Drugs to Human Plasma and Increases Uptake by Brain Microvascular Endothelial Cells

G. Merki-Feld, R. Dubey, B. Leeners, 2017, Phytotherapy research : PTR.

No effect of Implanon® on inflammatory cardiovascular parameters

K. Spanaus, G. Merki-Feld, B. Imthurn, 2011, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Ethinylestradiol/Drospirenone A Review of its Use as an Oral Contraceptive

G. Merki-Feld, F. Lüdicke, L. Bahamondes, 2003 .

Desogestrel-only contraception may reduce headache frequency and improve quality of life in women suffering from migraine

B. Seifert, G. Merki-Feld, A. Gantenbein, 2013, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Long-term effects of combined oral contraceptives on markers of endothelial function and lipids in healthy premenopausal women.

G. Merki-Feld, R. Dubey, P. Keller, 2002, Contraception.

Original research article Long-term effects of combined oral contraceptives on markers of endothelial function and lipids in healthy premenopausal women

G. Merki-Feld, P. Keller, M. Rosselli, 2002 .

Migraine and Use of Progestin-Only Contraception

G. Merki-Feld, 2019, Gender and Migraine.

Contraception in adolescents with anorexia nervosa. Is there evidence for a negative impact of combined hormonal contraceptives on bone mineral density and the course of the disease?

G. Merki-Feld, J. Bitzer, 2020, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

G. Merki-Feld, Joy-Fleur van der Vaart, 2022, Women's health.

Contraceptive drugs mitigate experimental stroke-induced brain injury

A. Luft, M. Weller, G. Merki-Feld, 2018, Cardiovascular research.

A prospective study on the effects of depot medroxyprogesterone acetate on trabecular and cortical bone after attainment of peak bone mass

G. Merki-Feld, M. Neff, P. Keller, 2000, BJOG : an international journal of obstetrics and gynaecology.

[Weight gain due to hormonal contraception: myth or truth?].

G. Merki-Feld, B. Imthurn, Daniela Häni, 2009, Gynakologisch-geburtshilfliche Rundschau.

Migraine start, course and features over the cycle of combined hormonal contraceptive users with menstrual migraine – temporal relation to bleeding and hormone withdrawal: a prospective diary-based study

G. Merki-Feld, E. MacGregor, Nina Caveng, 2020, The Journal of Headache and Pain.

Decrease in Endothelin-1 Plasma Levels during the Menstrual Cycle and after Ethinylestradiol Treatment

G. Merki-Feld, P. Keller, 1999, Annals of Internal Medicine.

Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim results

D. Viceic, H. Pohl, C. Kamm, 2022, The Journal of Headache and Pain.

Tubal Pathology: The Role of Hormonal Contraception, Intrauterine Device Use and Chlamydia trachomatis Infection

G. Merki-Feld, B. Leeners, B. Imthurn, 2006, Gynecologic and Obstetric Investigation.

High survival and developmental rates of vitrified mouse zygotes following polar body biopsy.

G. Merki-Feld, P. Pelczar, B. Imthurn, 2008, Reproductive biomedicine online.

Clinical experience with the combined contraceptive vaginal ring in Switzerland, including a subgroup analysis of previous hormonal contraceptive use

G. Merki-Feld, M. Hund, 2010, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Clinical experience with NuvaRing® in daily practice in Switzerland: Cycle control and acceptability among women of all reproductive ages

G. Merki-Feld, M. Hund, 2007, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

ESC expert statement on the effects on mood of the natural cycle and progestin-only contraceptives

G. Merki-Feld, D. Apter, L. Shulman, 2017, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Comparison of the proliferative effects of ethinylestradiol in an intermittent and a continuous dosing regime on human breast cancer cells Running title : Continuous and intermittent ethinylestradiol and breast cancer cell proliferation

G. Merki-Feld, A. Mueck, H. Seeger, 2009 .

Proposal to inform European institutions regarding the regulation of conscientious objection to abortion

Javier Mar, Oliver Ibarrondo, Sam Rowlands, 2016, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

A survey on Swiss women's preferred menstrual/withdrawal bleeding pattern over different phases of reproductive life and with use of hormonal contraception

B. Seifert, G. Merki-Feld, M. Kreft, 2014, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Is there a need for better sexual education of young men? Sexual behaviour and reproductive health in Swiss university students: a questionnaire-based pilot study

G. Merki-Feld, B. Imthurn, M. Stewart, 2018, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

The incidence of actinomyces-like organisms in Papanicolaou-stained smears of copper- and levonorgestrel-releasing intrauterine devices.

G. Merki-Feld, P. Keller, E. Lebeda, 2000, Contraception.

Comparison of two procedures for routine IUD exchange in women with positive Pap smears for actinomyces-like organisms.

G. Merki-Feld, B. Imthurn, M. Rosselli, 2008, Contraception.

Partial and complete expulsion of the Multiload 375 IUD and the levonorgestrel-releasing IUD after correct insertion.

G. Merki-Feld, B. Imthurn, P. Keller, 2008, European journal of obstetrics, gynecology, and reproductive biology.

Intrauterine device continuation rates and reasons for discontinuation in a Central European clinic with a high standard of care and ultrasound follow-up: a retrospective cohort study

G. Merki-Feld, B. Leeners, K. Blickenstorfer, 2018, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Erratum to “Partial and complete expulsion of the multiload 375 IUD and the levonorgestrel-releasing IUD after correct insertion” [Eur. J. Obstet. Gynecol. 137 (2008) 92–96]

G. Merki-Feld, B. Imthurn, P. Keller, 2009 .

European Society of Contraception Statement on Contraception in Obese Women

P. Crosignani, G. Merki-Feld, A. Cagnacci, 2015, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Effects of a combined oral contraceptive containing oestradiol valerate/dienogest on hormone withdrawal-associated symptoms: Results from the multicentre, randomised, double-blind, active-controlled HARMONY II study

G. Merki-Feld, U. Mellinger, M. Serrani, 2013, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

Are there unmet needs in contraceptive counselling and choice? Findings of the European TANCO Study

G. Merki-Feld, J. Bitzer, C. Caetano, 2018, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Positive effects of the progestin desogestrel 75 μg on migraine frequency and use of acute medication are sustained over a treatment period of 180 days

B. Seifert, G. Merki-Feld, A. Gantenbein, 2015, The Journal of Headache and Pain.

Proliferative Effects of Estradiol- or Ethinylestradiol-Progestogen Combinations on Human Breast Cancer Cells in an Intermitted and a Long-term Regimen

G. Merki-Feld, A. Mueck, H. Seeger, 2012, Hormone and Metabolic Research.

Six years after deregulation of emergency contraception in Switzerland: Has free access induced changes in the profile of clients attending an emergency pharmacy in Zürich?

B. Seifert, G. Merki-Feld, B. Imthurn, 2012, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenone

J. Foidart, C. Gerlinger, G. Merki-Feld, 2000, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Effect of exogenous estrogens and progestogens on the course of migraine during reproductive age: a consensus statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH)

T. Kurth, S. Sacco, G. Merki-Feld, 2018, The journal of headache and pain.

Headache frequency and intensity in female migraineurs using desogestrel-only contraception: A retrospective pilot diary study

G. Merki-Feld, A. Gantenbein, B. Imthurn, 2013, Cephalalgia : an international journal of headache.

Intention to use a combined contraceptive method and decision after counselling in Switzerland – Swiss data from the European CHOICE study

G. Merki-Feld, I. M. Gruber, Isabel M. L. Gruber, 2012, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Authors’ comment: Partial and complete expulsion of the Multiload 375 and the levonorgestrel-releasing IUD after correct insertion (Eur. J. Obstet. Gynecol. Reprod. Biol. 137 (2008) 92–96)

G. Merki-Feld, B. Imthurn, P. Keller, 2009 .

Broad counseling for adolescents about combined hormonal contraceptive methods: the choice study.

G. Merki-Feld, I. M. Gruber, Isabel M. L. Gruber, 2014, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

Bioequivalence and X-Ray Visibility of a Radiopaque Etonogestrel Implant versus a Non-Radiopaque Implant

G. Merki-Feld, P. Schnabel, I. Duijkers, 2012, Clinical Drug Investigation.

Original research article Nonpalpable ultrasonographically not detectable Implanon rods can be localized by magnetic resonance imaging

G. Merki-Feld, P. Keller, C. Brekenfeld, 2001 .

Effects of the progestagen‐only contraceptive implant Implanon® on cardiovascular risk factors

B. Seifert, G. Merki-Feld, B. Imthurn, 2008, Clinical endocrinology.

Effectiveness of the progestin-only pill for migraine treatment in women: A systematic review and meta-analysis

B. Brew, K. McGeechan, G. Merki-Feld, 2018, Cephalalgia : an international journal of headache.

Randomized comparison of bleeding patterns in women using a combined contraceptive vaginal ring or a low-dose combined oral contraceptive on a menstrually signaled regimen.

K. McGeechan, I. Fraser, G. Merki-Feld, 2015, Contraception.

Endometriosis features and dienogest tolerability in women with depression: a case-control study

M. Neumeier, G. Merki-Feld, P. Imesch, 2023, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Vitrification of human single pronuclear oocytes following two approaches to polar body biopsy.

G. Merki-Feld, B. Imthurn, M. Xie, 2011, Reproductive biomedicine online.

Correction to: Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)

T. Kurth, S. Sacco, G. Merki-Feld, 2018, The Journal of Headache and Pain.

Endometriosis Features in Women With and Without Migraine.

M. Neumeier, G. Merki-Feld, P. Imesch, 2023, Journal of women's health.

Correction: Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim results

I. Meyer, D. Viceic, C. Kamm, 2022, The journal of headache and pain.

The Effect of the Menstrual Cycle and of Ethinylestradiol on Nitric Oxide, Endothelin-1 and Homocysteine Plasma Levels

G. Merki-Feld, B. Imthurn, P. Keller, 2000, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[Contraception in perimenopause].

G. Merki-Feld, 2000, Therapeutische Umschau. Revue therapeutique.

T. Kurth, S. Sacco, G. Merki-Feld, 2017, The Journal of Headache and Pain.

Improvement of migraine with change from combined hormonal contraceptives to progestin-only contraception with desogestrel: How strong is the effect of taking women off combined contraceptives?

G. Merki-Feld, A. Gantenbein, R. Dubey, 2017, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

Migraine and Happiness

W. Ruch, M. Neumeier, G. Merki-Feld, 2022, Women's health reports.

Comparison of the Proliferative Effects of Ethinylestradiol on Human Breast Cancer Cells in an Intermittent and a Continuous Dosing Regime

G. Merki-Feld, A. Mueck, H. Seeger, 2008, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.